13 abril 2015
In response to nutrient excess, the MCRS1 protein acts as a ‘switch’ for mTOR, a protein that is altered in cancer, diabetes and disorders associated with aging. These results correlate with increased MCRS1 protein levels in samples taken from patients with colorectal cancer. Blocking this protein may prove to be an effective treatment for cancer or other diseases associated with mTOR alterations, researchers say.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/4xsT03frHos/150413130827.htm
